» Articles » PMID: 38567664

The Alcatraz-Strategy: a Roadmap to Break the Connectivity Barrier in Malignant Brain Tumours

Abstract

In recent years, the discovery of functional and communicative cellular tumour networks has led to a new understanding of malignant primary brain tumours. In this review, the authors shed light on the diverse nature of cell-to-cell connections in brain tumours and propose an innovative treatment approach to address the detrimental connectivity of these networks. The proposed therapeutic outlook revolves around three main strategies: (a) supramarginal resection removing a substantial portion of the communicating tumour cell front far beyond the gadolinium-enhancing tumour mass, (b) morphological isolation at the single cell level disrupting structural cell-to-cell contacts facilitated by elongated cellular membrane protrusions known as tumour microtubes (TMs), and (c) functional isolation at the single cell level blocking TM-mediated intercellular cytosolic exchange and inhibiting neuronal excitatory input into the malignant network. We draw an analogy between the proposed therapeutic outlook and the Alcatraz Federal Penitentiary, where inmates faced an impassable sea barrier and experienced both spatial and functional isolation within individual cells. Based on current translational efforts and ongoing clinical trials, we propose the Alcatraz-Strategy as a promising framework to tackle the harmful effects of cellular brain tumour networks.

Citing Articles

The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma.

Schneider M, Potthoff A, Ahmadipour Y, Borger V, Clusmann H, Combs S BMC Cancer. 2025; 25(1):306.

PMID: 39979825 PMC: 11843818. DOI: 10.1186/s12885-025-13682-3.


Cancer neuroscience and glioma: clinical implications.

Westphal M, Drexler R, Maire C, Ricklefs F, Lamszus K Acta Neurochir (Wien). 2025; 167(1):2.

PMID: 39752006 PMC: 11698767. DOI: 10.1007/s00701-024-06406-2.


Understanding brain cancer and exploiting its vulnerabilities.

Salomoni P Mol Oncol. 2024; 18(12):2817-2821.

PMID: 39582358 PMC: 11619798. DOI: 10.1002/1878-0261.13769.


Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression.

Liang J, Xie J, He J, Li Y, Wei D, Zhou R Cancer Rep (Hoboken). 2024; 7(10):e70031.

PMID: 39453684 PMC: 11505515. DOI: 10.1002/cnr2.70031.

References
1.
Skene J, Jacobson R, Snipes G, McGuire C, Norden J, Freeman J . A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science. 1986; 233(4765):783-6. DOI: 10.1126/science.3738509. View

2.
Yoo H, Kim Y, Nam B, Shin S, Yang H, Lee J . Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg. 2008; 110(4):730-6. DOI: 10.3171/2008.8.JNS08448. View

3.
Rogawski M, Hanada T . Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl. 2013; (197):19-24. PMC: 4506647. DOI: 10.1111/ane.12100. View

4.
Borger V, Schneider M, Taube J, Potthoff A, Keil V, Hamed M . Resection of piriform cortex predicts seizure freedom in temporal lobe epilepsy. Ann Clin Transl Neurol. 2020; 8(1):177-189. PMC: 7818082. DOI: 10.1002/acn3.51263. View

5.
Siam L, Bleckmann A, Chaung H, Mohr A, Klemm F, Barrantes-Freer A . The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study. Oncotarget. 2015; 6(30):29254-67. PMC: 4745724. DOI: 10.18632/oncotarget.4201. View